Resveratrol's Effects in Diabetic Nephropathy

Not Applicable

• Conditions: diabetes mellitus.; Non-insulin-dependent diabetes mellitus-diabetic nephropathy; E11-NO8.3

• Registration Number: IRCT2016100716876N2
• Lead Sponsor: Vice chancellor for research,shiraz university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Inclusion Criteria:
• Type 2 diabetes mellitus (DM)
• Controlled blood sugar [fasting blood sugar (FBS) <130mg/dl and glycosylated
hemoglobin (A1C)<7%
• Urine albumin >20mg/lit in two separate occasions during the last 3 months period
• Serum creatinin < or = 2mg/dl

Exclusion Criteria

• Pregnancy
• Lactation
• Alcoholism
• Liver failure (acute or chronic)
• Renal failure: serum creatinin >2mg/dl
• Glomerulonephritis
• Uncontrolled hypertension
• Congestive heart failure
• Prostate disease
• Malignancy
• Bilateral renal artery stenosis
• Any systemic disease other than DM
• Any infection or rheumatologic disorder
• Use of warfarin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rine albumin level. Timepoint: before intervention and 3 months after intervention. Method of measurement: miligram per deciliter with immunoturbidometry method.;Serum creatinin. Timepoint: before intervention and 3months after intervention. Method of measurement: miligram per deciliter.